E88: First principle politics, China chaos & outlook, state of private/public markets & more
2022-07-22 spoken.md · speaker-labeled ▶ watch ← E87 all episodes E89 →
Every number here is replayed from score_events — the same ledger the pool ranks on. Decay is what the 81 ideas nobody mentioned gave up this week; it applies only when an episode is processed.
Tier crossings
conviction thresholds crossed by this episode — 65 / 45 / 15 · ideas born here show where they landed. why 65 isn't always green
Kill dates that landed since E87
0 hit · 0 partial · 2 miss — windows that closed after 2022-07-14 and up to 2022-07-22, auto-scored against price data and never hand-set. verdict · R · α
| idea | verdict | R | α | closed |
|---|---|---|---|---|
| 🤖 3D printing has enormous upside as space manufacturing | MISS | -60.9% | -51.5 | 2022-07-16 |
| 🤖 Electric bikes reshape cities | MISS | -74.4% | -64.9 | 2022-07-16 |
Who moved the board
each voice's force on conviction this episode — supports and opposes, weighted exactly as the replay applied them · share = % of this episode's movement
What got argued (12 ideas)
ordered by how hard each idea moved · quotes are verbatim from the transcript, timestamps deep-link into the episode
China's three growth drivers are failing at once: manufacturing growth fell from 25% y/y in 2008 to 6% in 2022, real-estate sales post their first-ever decline after rising from 250M sqm (2005) to 1.5B sqm (2021), and financial services (8% of the economy, $58T of assets) is levered to both. Frozen deposits at rural banks, tanks outside branches, and mortgage boycotts across 301 unfinished developments in 91 cities are the visible cracks - Sacks calls it China's 2008. Chinese equities and financials carry the cost.
So a lot of the conflict and the things that are starting to fall apart, which may just be the tip of the iceberg, is a function of a fundamentally slowing economy and the forecast and the outlook for an economy that doesn't have the drivers it's had historically.
Amazon's $3.9B One Medical deal buys a busted post-IPO asset at roughly its January price (ONEM went from ~$60 in Feb 2021 to ~$7) and what it actually acquires is a network of doctors who can do telehealth plus a built-out retail footprint. The synergy chain is doctor visit into blood test into prescription fulfilled by Amazon pharmacy into diet delivered by Whole Foods, all locked behind Prime; Friedberg's dated call is that Amazon massively expands the telehealth footprint within a year of closing, on the theory Amazon already owns the customers One Medical was paying ~$1,000 CPA to acquire.
The $52B chip-bill subsidy is a one-time capex handout to companies that already misallocated their capital - Chamath's receipt is Intel authorizing ~$110B of buybacks and having $6-7B left - so it produces neither durable onshored capacity nor any lift to the recipients' enterprise value. Sustained tax breaks would change forecast earnings and get capitalized; free money does not. Scored on Intel, the named recipient whose capital allocation is the argument.
Jason's operator read: Chinese factory labour is now over $6/hr against $3 in Vietnam and less in India, and portfolio companies are already moving production to India, Vietnam and Japan. The cheap-labour manufacturing base relocates out of China to lower-cost Asia. Friedberg takes the other side - China does not concede the edge, it upgrades the factories to automated, higher-value output subsidised by cheap nuclear electricity.
What I feel smart about, I'll be honest, is we had, I think, let's just say, I'm making up a number here, four to five times we were offered the opportunity to trim our positions in secondary with our winners from people who wanted to buy secondary shares. I did it probably four out of five times.
Series B, C and D is where there's this whole fight because there's existing investors, existing shareholders who are saying, I don't want to take a 50% write down, a 70% write down, a 30% write down over the last round and fighting and then doing inside rounds and bridge notes and all sorts of other shenanigans to not have to take a negative mark on their book.
Episode digest
written during extraction and stored in data/extractions/ep088.json — the auditable source of truth, including everything market-adjacent that did not earn a capture
China dominated the tradeable content: Friedberg's zoom-out (manufacturing growth 25% to 6%, first-ever decline in real-estate sales, financial services levered to both) plus frozen rural-bank deposits, tanks outside branches and mortgage boycotts at 301 developments produced a new acute China-bust idea, with Sacks calling it China's 2008, while Chamath and Sacks' fertility-1.15 and 2100-population numbers spawned a separate structural demographic idea. Jason took a loud victory lap on the E42 China-self-own thesis and Sacks reinforced it; Friedberg was the lone dissenter, arguing China upgrades its factories with 400 nuclear plants and cheap power rather than losing them to Vietnam and India. The chip-bill segment produced a new bearish-Intel idea - Chamath's receipt is $110B of buybacks followed by a request for a handout - with Friedberg the only one defending the subsidy. Two reversals: Chamath, the proposer of the eighth-inning tech-bottom call, now says cash on the sidelines at 2008 highs means 'there is no reason to buy' (the exact inverse of his E64 argument), and Friedberg, proposer of the founder-led-fintech-beats-post-Bezos-Amazon thesis, praised Amazon's One Medical deal as proof the company still innovates without Bezos. Private markets were all confirmation - Chamath's 'constipation' cascade, Friedberg's 30-70% B/C/D write-downs, Sacks' 100x-to-20x ARR reset and Jason's secondary trimming - with Jason the sole dissenter on deploying, promising to do twice as many seed deals. Diarization is CLEAN (Jason top talker at 133 turns, all addressed-by-name and fingerprint checks pass); the two SPEAKER_3 turns are cold-open baby/dog banter with no captures.